The choice turns on whether you look first at fine lines, pores, and texture or at firmness, hydration, and laxity. Fine lines, pores, and texture point to Juvelook. Firmness, hydration, and laxity point to Profhilo. Juvelook combines PDLLA particles with hyaluronic acid. The particles stimulate the skin to make collagen. Profhilo is a hybrid that holds high- and low-molecular-weight hyaluronic acid in one product.
At a glance
Juvelook uses PDLLA particles designed to stimulate collagen production. Profhilo is high-concentration hyaluronic acid that draws water.
In a preliminary study, Juvelook was given at 4-week intervals for 2 or 3 sessions. Profhilo is 2 sessions 30 days apart, then a maintenance check at 2 months.
Nodules have been reported with both. If vision blurs or the skin turns suddenly white, contact the clinic that treated you immediately and seek emergency care.
Fine lines first, or laxity first?
Which to consider first depends on your main concern.
| Concern that comes first | Review this first | Why |
|---|---|---|
| Fine lines, texture, pores | Juvelook | Delivers PDLLA particles |
| Firmness, laxity, hydration | Profhilo | Delivers high-concentration hyaluronic acid |
| The eye area | Juvelook eye-area product | A separate eye-area product exists |
| The body | Profhilo Body | The body product differs from the face product in content and total amount |
| When nodules are the worry | Check both | For Juvelook, follow the nodule guide. For Profhilo, check how swelling, redness, and pain proceed, and whether a firm area remains |
| When the course should stay at two or three visits | Both fit | The Juvelook preliminary study used 2 or 3 sessions. The Profhilo course is 2. Spacing is about a month |
What does each one place in the skin?
PDLLA is poly-D,L-lactic acid, a particle built from lactic acid. According to the manufacturer, Juvelook is designed to increase the skin's own collagen with these particles, and it addresses texture, fine lines, and pores. The hyaluronic acid placed with it is non-cross-linked. Juvelook Volume and the eye-area product are separate from the face product.
The post-marketing safety report describes Profhilo as a hybrid hyaluronic acid made with IBSA's thermal process, NAHYCO. Its hyaluronic acid concentration is higher than that of cross-linked fillers. The hyaluronic acid draws water, adds hydration and firmness, and addresses laxity. It received CE marking in Europe in 2015. The body product differs from the face product in content and total amount.
| Item | Juvelook | Profhilo |
|---|---|---|
| Face product content | Per vial: PDLLA 42.5 mg + hyaluronic acid 7.5 mg | Hyaluronic acid 64 mg (32 mg + 32 mg), 2 mL |
| Other product content | Volume, per vial: PDLLA 170 mg + hyaluronic acid 30 mg. Eye area, per vial: PDLLA 25.5 mg + hyaluronic acid 4.5 mg | Body: hyaluronic acid 48 mg + 48 mg, 3 mL |
| What it does | Particles that stimulate collagen, plus non-cross-linked hyaluronic acid | Heat-treated, high-concentration hyaluronic acid. Hydration, firmness, laxity |
| Concern it addresses | Texture, fine lines, pores | Wrinkles, laxity, hydration |
For the treatment course, see "Juvelook effects and duration" and "Profhilo, HILO WAVE, and Re2O comparison." To compare ingredients with Rejuran and GOURI, see Skin booster types.
When is the change checked again?
A Juvelook preliminary study gave 2 or 3 sessions at 4-week intervals and compared the change at each visit. Fine lines, texture, pigment, and redness differed from before treatment. In the dermis behind the ear of people who consented to a biopsy, collagen and elastic fibers increased. No severe adverse event appeared in that study.
For Profhilo, maintenance is judged at the visit 2 months after the last session, and the same judgment is repeated every 2 months after that.
How many sessions, and how far apart?
In a preliminary study, Juvelook was given every 4 weeks for 2 or 3 sessions. How much discomfort you feel changes with the area, the way it is placed, and anesthesia. The injection goes into the dermis, and the face and the area behind the ear were treated the same way.
The basic Profhilo schedule is 2 sessions, 30 days apart. On the face that is five points on each side, 0.2 mL at each point, into the dermis. Both sides together are 2 mL. Maintenance spacing is 2 months, and that visit sets the next session. The body product differs from the face product in content and total amount.
| Item | Juvelook | Profhilo |
|---|---|---|
| Sessions in the record | 2 or 3 in a preliminary study | 2 |
| Spacing | 4 weeks | 30 days |
| After that | Change is checked at each session | Maintenance check at 2 months, then every 2 months |
| Where it is placed | Dermis, face | Dermis, five points on each side |
How do normal downtime and nodules differ?
Juvelook leaves temporary redness, swelling, tenderness, and bruising at the treated spots. Apart from that, a firm red nodule and a nodule felt without inflammation are known complications. Uneven spread is the reason for the nodule without inflammation. Cases where the material entered a blood vessel have led to vision loss and stroke. The check sequence is in the Juvelook nodule guide.
Swelling, redness, and pain are reported after Profhilo. If swelling grows or pain worsens, contact the clinic that treated you. Nodules and vascular occlusion have also been reported. If vision blurs or the skin turns suddenly white, contact the clinic that treated you immediately and seek emergency care.
What changes the price?
Three things change the price: the product (Juvelook, Juvelook Volume, the eye-area product, or Profhilo), the area (face, eye area, or body), and the course (2 sessions, 3 sessions, or maintenance at 2 months). For how the quote is itemized, see the Juvelook treatment page and the Profhilo treatment page.
What do you check before treatment?
Confirm these six points out loud before treatment.
- □ Whether today's product is Juvelook, Juvelook Volume, or the eye-area product
- □ Whether Profhilo is the face product or the body product
- □ Whether the spacing is the Juvelook preliminary study's 4 weeks and 2 or 3 sessions, or Profhilo's 30 days and 2 sessions with maintenance at 2 months
- □ Whether the first concern is fine lines, pores, and texture, or firmness, hydration, and laxity
- □ Whether your calendar leaves room to skip strenuous exercise, saunas, hot baths, and alcohol for a short period afterward
- □ Where to call if a nodule is felt or vision blurs
Frequently asked questions
Q1. Can both be done on the same day?
Each product's session spacing does not tell you whether the two can be done on the same day. Before treatment, confirm a combined plan, including the area and the amount placed, with the clinician in charge.
Q2. How many months does it last?
The 4 weeks and 2 months in this article mean the spacing of treatment and reassessment. Our sources do not state how many months the effect lasts, so this article gives no figure. The Juvelook preliminary study checks the change at each session, 4 weeks apart. After 2 Profhilo sessions, maintenance is reviewed every 2 months.
Q3. What do the treatment day and the next three days look like?
On the treatment day and for the next three days, skip strenuous exercise, saunas, hot baths, and alcohol.
Q4. What if a nodule appears?
Contact the clinic that treated you. For Juvelook, separate a firm red nodule from a nodule felt without inflammation, and follow the nodule guide. For Profhilo, check how swelling, redness, and pain proceed, and whether a firm area remains. If vision blurs or the skin turns suddenly white, contact the clinic that treated you immediately and seek emergency care.
Q5. What about the eye area and the body?
The eye area is the Juvelook eye-area product. The body is Profhilo Body, and it differs from the face product in content and total amount.
Sources
- VAIM: Juvelook official site: vial ingredients
- VAIM: Juvelook product page
- Seo SB et al. (2024), J Cosmet Dermatol: Skin rejuvenation effect of the combined PDLLA and non cross-linked hyaluronic acid: A preliminary study (PMID 37969055)
- Salti G et al. (2025), J Cosmet Dermatol: Hyaluronic Acid Hybrid Cooperative Complexes Nearing 10 Years of Use: Update on Safety Assessment Based on Post-Marketing Surveillance Data (PMID 40654100, PMC12257262)
- Lee KWA et al. (2024), Polymers (Basel): Poly-d,l-lactic Acid (PDLLA) Application in Dermatology: A Literature Review (PMID 39339047, PMC11434839)
This article is general information and does not replace individual medical care.
Discuss options for your current needs
We review your current health and prior procedures before explaining appropriate options and their limits.
